Novo Nordisk raises full-year forecast on GLP-1 drug sales Ruchika Sharma16 April 2023 10:00 AM ISTThe guidance upgrade also partly reflected higher expected sales in the U.S. of its Ozempic diabetes drug, which is based on the same active...
Novo Nordisk, Dewpoint Therapeutics collaborate to explore field of biomolecular condensates to treat insulin resistance, diabetes progression Ruchika Sharma24 March 2023 10:00 AM ISTBoston: Dewpoint Therapeutics has announced a research and development partnership with Novo Nordisk to identify drug candidates using Dewpoint's...
Novo Nordisk diabetes drug Ozempic back on shelves in US after months of shortage Ruchika Sharma19 March 2023 1:00 PM ISTUS: Novo Nordisk's best-selling diabetes treatment drug Ozempic is back on the shelves in the United States after months of shortage, the U.S....
British pharma trade body suspends Novo Nordisk for 2 years over serious breaches Ruchika Sharma17 March 2023 3:42 PM ISTLondon: British pharma trade body, the Association of the British Pharmaceutical Industry (ABPI), has said it has suspended Danish drugmaker Novo...
Novo Nordisk to cut US list prices for several insulin products by up to 75 percent next year Ruchika Sharma15 March 2023 3:15 PM ISTThe Danish drugmaker will reduce the list price of its NovoLog insulin by 75%, and for Novolin and Levemir by 65%.
USFDA approves label update for Rybelsus allowing use as first-line option for adults with type 2 diabetes: Novo Nordisk Ruchika Sharma16 Jan 2023 4:15 PM ISTPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved a label update for Rybelsus (semaglutide) tablets...
An effective Obesity drug has now been approved for teens Roshni Dhar30 Dec 2022 5:41 PM ISTThe Food and Drug Administration (FDA) has recently expanded the eligibility of Novo Nordisk's Wegovy, a medication indicated for the treatment of...
Health Bulletin 30/December/2022 Roshni Dhar30 Dec 2022 4:55 PM ISTHere are the top health news for the day:India reports 268 new Covid-19 infections; active cases rise to 3,552According to the Ministry of Health and...
Novo Nordisk gets CDSCO Panel nod to study NN0365-3769 Dr. Divya Colin18 Dec 2022 5:00 PM ISTNew Delhi: In a significant development, the drug major Novo-Nordisk has got approval from the Subject Expert Committee (SEC) functional under the...
Novo Nordisk to boost obesity drugs manufacturing capacity Ruchika Sharma6 Nov 2022 12:00 PM ISTFrankfurt: Novo Nordisk said it will boost manufacturing capacity for future obesity drug launches and worry less about marketing and advertising...
Novo Nordisk, Ventus Therapeutics collaborate for NLRP3 Inhibitor Program Ruchika Sharma5 Oct 2022 11:00 AM ISTVentus retains the right to develop NLRP3 inhibitors for certain systemic diseases, including specific inflammatory and respiratory diseases.
Novo Nordisk, Zealand Pharma collaborate for ZEGALOGUE for injection Ruchika Sharma9 Sept 2022 11:33 AM ISTUnder the terms of the agreement, Zealand will receive an upfront payment of DKK 25 million and is eligible to receive up to DKK 45 million in...
